• 1. Celgene Risk Management

  celgeneriskmanagement.com

  Link: https://celgeneriskmanagement.com/REMSPortal/rems/portal/REMSPortal.portal

  Description: WebCelgene Risk Management. Welcome to the REMS Program Administered by Celgene. To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs …

  DA: 50 PA: 100 MOZ Rank: 34

• 2. Celgene REMS Pharmacy Portal

  celgeneremspharmacyportal.com

  Link: https://celgeneremspharmacyportal.com/REMSPharmacyPortal/remspharmacy/portal/REMSPharmacyPortal.portal

  Description: WebWelcome to the Pharmacy Portal for Celgene-administered REMS Programs To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are …

  DA: 43 PA: 82 MOZ Rank: 13

• 3. Celgene Global Office Locations - Find Celgene Around the World

  celgene.com

  Link: https://www.celgene.com/global-office-locations/

  Description: WebCelgene is impacting the lives of patients with cancer and other serious diseases in more than 50 countries worldwide. Choose Country. Font Size. About. Compliance. Global …

  DA: 100 PA: 7 MOZ Rank: 10

• 4. Celgene - Wikipedia

  wikipedia.org

  Link: https://en.wikipedia.org/wiki/Celgene

  Description: OverviewHistoryProductsPipelineLitigationSee alsoExternal linksCelgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). Number of employees: 8,852 (2018) Founded: 1986; 36 years ago Revenue: $15.281 billion (2018)

  Number of employees: 8,852 (2018)Founded: 1986; 36 years agoRevenue: $15.281 billion (2018)

  DA: 14 PA: 7 MOZ Rank: 43

• 5. Global Biopharmaceutical Company - Bristol Myers …

  bms.com

  Link: https://www.bms.com/

  Description: WebJun 16, 2022 · Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

  DA: 7 PA: 28 MOZ Rank: 72

• 6. Celgene | CELG Stock Price, Company Overview & News - Forbes

  forbes.com

  Link: https://www.forbes.com/companies/celgene/

  Description:

  DA: 10 PA: 62 MOZ Rank: 20

• 7. Investors Home | Celgene Corporation

  celgene.com

  Link: https://ir.celgene.com/investors/default.aspx

  Description: WebOct 31, 2019 · Celgene is now part of Bristol Myers Squibb creating a leading biopharma company positioned to address the needs of patients with serious diseases.

  DA: 31 PA: 59 MOZ Rank: 84

• 8. Medical Innovation: Celgene Target Identification

  celgene.com

  Link: https://www.celgene.com/research-development/medical-innovation/

  Description: WebCelgene has developed target-identification and drug-discovery technology platforms that enable the Company to proceed rapidly from target identification and validation through lead identification and optimization. …

  DA: 50 PA: 3 MOZ Rank: 29

• 9. Bristol-Myers Squibb to Acquire Celgene to Create a Premier …

  celgene.com

  Link: https://ir.celgene.com/press-releases-archive/press-release-details/2019/Bristol-Myers-Squibb-to-Acquire-Celgene-to-Create-a-Premier--Innovative-Biopharma-Company/default.aspx

  Description: WebJan 3, 2019 · Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company. Highly Complementary Portfolios with Leading Franchises in …

  DA: 81 PA: 11 MOZ Rank: 7

• 10. Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a

  bms.com

  Link: https://news.bms.com/news/corporate-financial/2019/Bristol-Myers-Squibb-Completes-Acquisition-of-Celgene-Creating-a-Leading-Biopharma-Company/default.aspx

  Description: WebNov 20, 2019 · Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt …

  DA: 86 PA: 79 MOZ Rank: 44